ArticleFrontiers in pharmacology2024

Sequential versus concomitant treatment of androgen receptor signaling inhibitors and docetaxel for metastatic hormone-sensitive prostate cancer: an network meta-analysis.

Chun Xing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.